PAPER Idrizbegovic E, Hederstierna C, Dahlquist M, Rosenhall U
SEARCH RESULTS
330988 RESULTS
PAPER Paajanen T, Hänninen T, Aitken A, Hallikainen M, Westman E, Wahlund LO, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H, AddNeuroMed Consortium
CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease.
Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):446-58. Epub 2013 Nov 30 PubMed: 24516412PAPER Ponnayyan Sulochana S, Sharma K, Mullangi R, Sukumaran SK
Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease.
Biomed Chromatogr. 2014 Feb 11; PubMed: 24515838PAPER Kaiser NC, Liang LJ, Melrose RJ, Wilkins SS, Sultzer DL, Mendez MF
Differences in anxiety among patients with early- versus late-onset Alzheimer's disease.
J Neuropsychiatry Clin Neurosci. 2014;26(1):73-80. PubMed: 24515678PAPER Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N
In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
Eur J Nucl Med Mol Imaging. 2014 May;41(5):816-26. Epub 2014 Feb 11 PubMed: 24514874PAPER Sharp DJ, Scott G, Leech R
Network dysfunction after traumatic brain injury.
Nat Rev Neurol. 2014 Mar;10(3):156-66. Epub 2014 Feb 11 PubMed: 24514870PAPER Hughes ME, Peeler J, Hogenesch JB, Trojanowski JQ
The growth and impact of Alzheimer disease centers as measured by social network analysis.
JAMA Neurol. 2014 Apr;71(4):412-20. PubMed: 24514750PAPER Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL
Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.
JAMA Neurol. 2014 Apr;71(4):429-35. PubMed: 24514572PAPER Jones T, Hungerford C, Cleary M
Pharmacological versus non-pharmacological approaches to managing challenging behaviours for people with dementia.
Br J Community Nurs. 2014 Feb;19(2):72-7. PubMed: 24514107PAPER Hatayama Y, Hashimoto T, Kohayakawa H, Kiyoshi T, Nakamichi K, Kinoshita T, Yoshida N
In vivo pharmacological characterization of AC-3933, a benzodiazepine receptor partial inverse agonist for the treatment of Alzheimer's disease.
Neuroscience. 2014 Apr 18;265:217-25. Epub 2014 Feb 8 PubMed: 24513386PAPER Sugiki T, Utsunomiya-Tate N
Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β
Biochem Biophys Res Commun. 2013 Oct 25; PubMed: 24513210PAPER Exley C, Vickers T
Elevated brain aluminium and early onset Alzheimer's disease in an individual occupationally exposed to aluminium: a case report.
J Med Case Rep. 2014 Feb 10;8:41. PubMed: 24513181PAPER Jin F, Gong QH, Xu YS, Wang LN, Jin H, Li F, Li LS, Ma YM, Shi JS
Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Int J Neuropsychopharmacol. 2014 Jun;17(6):871-81. Epub 2014 Feb 11 PubMed: 24513083PAPER Xu PX, Wang SW, Yu XL, Su YJ, Wang T, Zhou WW, Zhang H, Wang YJ, Liu RT
Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
Behav Brain Res. 2014 May 1;264:173-80. Epub 2014 Feb 7 PubMed: 24512768PAPER Mendiratta P, Wei JY
Diagnosing Alzheimer's disease: update for the primary care clinician.
J Ark Med Soc. 2014 Jan;110(8):160-3. PubMed: 24511859Current Filters
No filters selected